1. Home
  2. HCM vs LU Comparison

HCM vs LU Comparison

Compare HCM & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • LU
  • Stock Information
  • Founded
  • HCM 2000
  • LU 2005
  • Country
  • HCM Hong Kong
  • LU China
  • Employees
  • HCM N/A
  • LU N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • LU Finance: Consumer Services
  • Sector
  • HCM Health Care
  • LU Finance
  • Exchange
  • HCM Nasdaq
  • LU Nasdaq
  • Market Cap
  • HCM 2.5B
  • LU 2.1B
  • IPO Year
  • HCM N/A
  • LU 2020
  • Fundamental
  • Price
  • HCM $13.89
  • LU $2.94
  • Analyst Decision
  • HCM Hold
  • LU Hold
  • Analyst Count
  • HCM 1
  • LU 2
  • Target Price
  • HCM $19.00
  • LU $2.98
  • AVG Volume (30 Days)
  • HCM 62.8K
  • LU 3.8M
  • Earning Date
  • HCM 03-19-2025
  • LU 06-10-2025
  • Dividend Yield
  • HCM N/A
  • LU 80.89%
  • EPS Growth
  • HCM N/A
  • LU N/A
  • EPS
  • HCM 0.04
  • LU N/A
  • Revenue
  • HCM $630,201,000.00
  • LU $4,671,260,668.00
  • Revenue This Year
  • HCM $14.86
  • LU N/A
  • Revenue Next Year
  • HCM $19.54
  • LU N/A
  • P/E Ratio
  • HCM $63.20
  • LU N/A
  • Revenue Growth
  • HCM N/A
  • LU N/A
  • 52 Week Low
  • HCM $11.51
  • LU $2.00
  • 52 Week High
  • HCM $21.50
  • LU $4.58
  • Technical
  • Relative Strength Index (RSI)
  • HCM 50.07
  • LU 50.48
  • Support Level
  • HCM $13.13
  • LU $2.83
  • Resistance Level
  • HCM $13.66
  • LU $3.15
  • Average True Range (ATR)
  • HCM 0.36
  • LU 0.14
  • MACD
  • HCM 0.05
  • LU 0.00
  • Stochastic Oscillator
  • HCM 81.25
  • LU 36.99

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About LU Lufax Holding Ltd each representing two (2)

Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.

Share on Social Networks: